Preventing depression relapse / recurrence in NHS settings through mindfulness-based cognitive therapy (MBCT). - PREVENT

niversity of Exeter0 sites420 target enrollmentOctober 1, 2009

Overview

No summary available.

Registry

who.int

Start Date

October 1, 2009

End Date

TBD

Last Updated

14 years ago

Study Type

Interventional clinical trial of medicinal product

Sex

All

Sponsor

niversity of Exeter

•Inclusion: A diagnosis of recurrent major depressive disorder in full or partial remission according to the DSM\-IV, with 3 or more previous major depressive episodes; aged 18 or older; and on a therapeutic dose of ADM in line with the British National Formulary (BNF) and NICE guidance. We include older adults with depression on the basis of the high prevalence of depression in older adults and a promising pilot study of MBCT with this group (Smith, 2004\).
•Exclusion: patients who are currently depressed, co\-morbid diagnoses of current substance dependence; organic brain damage; current/past psychosis, including bipolar disorder; persistent antisocial behaviour; persistent self\-injury requiring clinical management/therapy; and formal concurrent psychotherapy.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1\.2 Adults (18\-64 years) yes
•F.1\.2\.1 Number of subjects for this age range
•F.1\.3 Elderly (\>\=65 years) yes
•F.1\.3\.1 Number of subjects for this age range

•Currently depressed, co\-morbid diagnoses of current substance dependence; organic brain damage; current/past psychosis, including bipolar disorder; persistent anti\-social behaviour; persistent self\-injury requiring clinical management/therapy; and formal concurrent psychotherapy.